While it is very much known that women do encounter fear for the traditional pap smear, a cervical cancer kit is reported to be unveiled soon. There are efforts being made to reach out to those women who are battling with the disease, it has been found that more or less women are apprehensive to go for the test.
The Delphi Screener has been made by Delphi Bioscience Asia Pte Ltd, which is a collaborative venture of Delphi Bioscience BV, a life sciences company, and its Singapore partners Tay and businessman David Tan.
It was further told that the kit has a cylindrical shape and round tip which can be inserted to the top of the cervix in order to collect cells with the help of a sterile, saline liquid, and further it is sent for Human Papilloma Virus (HPV) verification. However, in a pap smear test, cells extracted from the cervix are tested under a microscope.
In comparison to the pap smear test worth S$30-40, the screener is worth S$79.90 ($63), including the laboratory test, confirmed Singapore gynecological oncologist Tay Eng Hseon, who is of the view that there are many factors which are some or the other way inhibiting women to go for the screening.
There are expectations that it would be made available to as many as 100 family physician clinics in Singapore in the coming three months, and if things went well, then the Southeast Asian city-state might also host the launch of the screener.
While there are some regulatory hurdles in China, the Executive Managing Director (commercial) at Delphi Bioscience Asia confirmed that there are fair chances for the screener to be sold in considerable number in Indonesia and Malaysia.
With as many as about 500,000 new cases and 250,000 deaths each year, cervical cancer needs to be taken seriously to ensure that they get the best possible treatment.
Source: http://topnews.net.nz/content/221890-home-based-cervical-cancer-test-kit-may-counter-fear-women
yorkshire pudding larry the cable guy miracle on 34th street santa tracker monkey bread letter from santa sweet potato pie
No comments:
Post a Comment